ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 075,68
0,99%
Dow Jones
38 884,26
0,08%
DAX
18 430,05
1,42%
Brent Oil
82,865
-0,73%
Bitcoin
62 773,22
-0,61%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. 180 Life Sciences Corporation (ATNF)

  7. 180 Life Sciences Corporation (ATNF) Actualités

ATNF 180 Life Sciences Corporation

2,01
0,14 (7,49%)
Après les heures de négociation
Dernière mise à jour : 22:47:36
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
180 Life Sciences Corporation ATNF NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,14 7,49% 2,01 22:47:36
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,90 1,90 2,3583 2,01 1,87
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
14/3/202413:30GLOBE180 Life Sciences Regains Full Compliance with Nasdaq ..
11/3/202412:03EDGAR2Form 8-K - Current report
08/3/202422:49EDGAR2Form 8-K - Current report
29/2/202414:00EDGAR2Form 8-K - Current report
28/2/202412:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202412:39EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202412:37EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202412:30EDGAR2Form 8-K - Current report
26/2/202413:00EDGAR2Form 8-K - Current report
26/2/202413:00GLOBE180 Life Sciences Corp. Announces 1-For 19 Reverse Stock..
20/2/202414:01EDGAR2Form 8-K - Current report
16/2/202423:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202423:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202423:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202422:15EDGAR2Form 8-K - Current report
12/2/202422:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/1/202423:29EDGAR2Form S-1 - General form for registration of securities under..
29/1/202414:00EDGAR2Form 8-K - Current report
17/1/202414:30EDGAR2Form 8-K - Current report
16/1/202414:30EDGAR2Form 8-K - Current report
29/12/202300:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/12/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
21/12/202323:00EDGAR2Form 8-K - Current report
20/12/202314:00EDGAR2Form 8-K - Current report
18/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:30EDGAR2Form 8-K - Current report
14/12/202322:30EDGAR2Form PRE 14A - Other preliminary proxy statements
04/12/202315:00EDGAR2Form 8-K - Current report
04/12/202315:00GLOBE180 Life Sciences Engages Financial Advisor to Explore..
30/11/202323:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/11/202323:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/11/202314:10EDGAR2Form 8-K - Current report
28/11/202315:00EDGAR2Form 8-K - Current report
28/11/202315:00GLOBE180 Life Sciences Announces Review of Strategic Alternatives
16/11/202322:30EDGAR2Form 8-K - Current report
09/11/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/10/202322:33EDGAR2Form 8-K - Current report
13/10/202323:00EDGAR2Form 8-K - Current report
28/9/202322:18EDGAR2Form 8-K - Current report
22/9/202315:00EDGAR2Form 8-K - Current report
08/9/202322:30EDGAR2Form 8-K - Current report
08/9/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202314:30EDGAR2Form 8-K - Current report
07/9/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202300:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/8/202323:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202323:26EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Dernières Valeurs Consultées

NASDAQ
ATNF
180 Life Sciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés